JP2019513821A5 - - Google Patents

Download PDF

Info

Publication number
JP2019513821A5
JP2019513821A5 JP2019502538A JP2019502538A JP2019513821A5 JP 2019513821 A5 JP2019513821 A5 JP 2019513821A5 JP 2019502538 A JP2019502538 A JP 2019502538A JP 2019502538 A JP2019502538 A JP 2019502538A JP 2019513821 A5 JP2019513821 A5 JP 2019513821A5
Authority
JP
Japan
Prior art keywords
serotype
polypeptide
item
group
unique
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019502538A
Other languages
English (en)
Japanese (ja)
Other versions
JP7164200B2 (ja
JP2019513821A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/025621 external-priority patent/WO2017173415A2/en
Publication of JP2019513821A publication Critical patent/JP2019513821A/ja
Publication of JP2019513821A5 publication Critical patent/JP2019513821A5/ja
Priority to JP2022111088A priority Critical patent/JP2022130741A/ja
Application granted granted Critical
Publication of JP7164200B2 publication Critical patent/JP7164200B2/ja
Priority to JP2023152185A priority patent/JP2023166591A/ja
Priority to JP2025095460A priority patent/JP2025124888A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019502538A 2016-03-31 2017-03-31 サッカライド－ポリペプチドコンジュゲートの組成物およびその使用の方法 Active JP7164200B2 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2022111088A JP2022130741A (ja) 2016-03-31 2022-07-11 サッカライド－ポリペプチドコンジュゲートの組成物およびその使用の方法
JP2023152185A JP2023166591A (ja) 2016-03-31 2023-09-20 サッカライド－ポリペプチドコンジュゲートの組成物およびその使用の方法
JP2025095460A JP2025124888A (ja) 2016-03-31 2025-06-09 サッカライド－ポリペプチドコンジュゲートの組成物およびその使用の方法

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201662316555P 2016-03-31 2016-03-31
US62/316,555 2016-03-31
US201662330245P 2016-05-02 2016-05-02
US62/330,245 2016-05-02
US201662372263P 2016-08-08 2016-08-08
US62/372,263 2016-08-08
US201662373807P 2016-08-11 2016-08-11
US62/373,807 2016-08-11
PCT/US2017/025621 WO2017173415A2 (en) 2016-03-31 2017-03-31 Saccharide-polypeptide conjugate compositions and methods of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022111088A Division JP2022130741A (ja) 2016-03-31 2022-07-11 サッカライド－ポリペプチドコンジュゲートの組成物およびその使用の方法

Publications (3)

Publication Number Publication Date
JP2019513821A JP2019513821A (ja) 2019-05-30
JP2019513821A5 true JP2019513821A5 (https=) 2020-05-14
JP7164200B2 JP7164200B2 (ja) 2022-11-01

Family

ID=59965349

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2019502538A Active JP7164200B2 (ja) 2016-03-31 2017-03-31 サッカライド－ポリペプチドコンジュゲートの組成物およびその使用の方法
JP2022111088A Revoked JP2022130741A (ja) 2016-03-31 2022-07-11 サッカライド－ポリペプチドコンジュゲートの組成物およびその使用の方法
JP2023152185A Pending JP2023166591A (ja) 2016-03-31 2023-09-20 サッカライド－ポリペプチドコンジュゲートの組成物およびその使用の方法
JP2025095460A Pending JP2025124888A (ja) 2016-03-31 2025-06-09 サッカライド－ポリペプチドコンジュゲートの組成物およびその使用の方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2022111088A Revoked JP2022130741A (ja) 2016-03-31 2022-07-11 サッカライド－ポリペプチドコンジュゲートの組成物およびその使用の方法
JP2023152185A Pending JP2023166591A (ja) 2016-03-31 2023-09-20 サッカライド－ポリペプチドコンジュゲートの組成物およびその使用の方法
JP2025095460A Pending JP2025124888A (ja) 2016-03-31 2025-06-09 サッカライド－ポリペプチドコンジュゲートの組成物およびその使用の方法

Country Status (4)

Country Link
US (2) US11058757B2 (https=)
EP (2) EP3436061A4 (https=)
JP (4) JP7164200B2 (https=)
WO (1) WO2017173415A2 (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3436061A4 (en) * 2016-03-31 2019-12-04 Liffey Biotech Limited Saccharide-polypeptide-conjugate compositions and methods of use thereof
CN110366428B (zh) 2016-12-30 2024-05-17 Vaxcyte公司 具有非天然氨基酸的多肽-抗原缀合物
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
US10729763B2 (en) 2017-06-10 2020-08-04 Inventprise, Llc Mixtures of polysaccharide-protein pegylated compounds
GB201711637D0 (en) * 2017-07-19 2017-08-30 Glaxosmithkline Biologicals Sa Immunogenic composition
GB201711635D0 (en) * 2017-07-19 2017-08-30 Glaxosmithkline Biologicals Sa Immunogenic composition
CN111093650B (zh) * 2017-09-07 2024-03-01 默沙东有限责任公司 肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途
MX394768B (es) 2017-09-07 2025-03-21 Merck Sharp & Dohme Llc Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina.
WO2019050814A1 (en) 2017-09-07 2019-03-14 Merck Sharp & Dohme Corp. ANTI-PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC CONJUGATES POLYSACCHARIDE-PROTEIN CARRIER
MX394767B (es) 2017-09-07 2025-03-24 Merck Sharp & Dohme Llc Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina transportadora.
US11524076B2 (en) 2017-09-07 2022-12-13 Merck Sharp & Dohme Llc Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
WO2019070994A1 (en) * 2017-10-04 2019-04-11 Liffey Biotech Limited SACCHARIDE-POLYPEPTIDE CONJUGATE COMPOSITIONS AND METHODS OF USE
ES3058336T3 (es) * 2017-12-06 2026-03-10 Merck Sharp & Dohme Llc Composiciones que comprenden conjugados polisacárido-proteína de Streptococcus pneumoniae y métodos de uso de los mismos
EP3749357A4 (en) 2018-02-05 2022-04-20 Sanofi Pasteur, Inc. POLYVALENT PNEUMOCOCCAL POLYSACCHARIDE PROTEIN CONJUGATE COMPOSITION
US11951162B2 (en) 2018-04-18 2024-04-09 Sk Bioscience Co., Ltd. Streptococcus pneumoniae capsular polysaccharides and immunogenic conjugate thereof
DK3817775T3 (da) * 2018-07-04 2024-09-16 Vaxcyte Inc Forbedringer i immunogene konjugater
MX2021003358A (es) * 2018-09-23 2021-05-27 Biological E Ltd Polisacaridos capsulares purificados de streptococcus pneumoniae.
IL284349B2 (en) * 2018-10-12 2025-06-01 Biological E Ltd Multivalent pneumococcal polysaccharide-protein conjugate vaccine
CA3120922A1 (en) * 2018-12-12 2020-06-18 Pfizer Inc. Immunogenic multiple hetero-antigen polysaccharide-protein conjugates and uses thereof
CR20210333A (es) * 2018-12-19 2021-08-18 Merck Sharp & Dohme Composiciones que comprenden conjugados de polisacárido de streptococcus pneumoniae con proteína y sus métodos de uso
WO2020208502A1 (en) * 2019-04-10 2020-10-15 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
BR112021024491A8 (pt) * 2019-06-05 2023-04-11 Merck Sharp & Dohme Composição imunogênica, e, método para prevenir, tratar ou melhorar uma infecção, doença ou condição
WO2022035816A1 (en) * 2020-08-10 2022-02-17 Inventprise, Llc Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24f
CA3200602A1 (en) * 2020-11-04 2022-05-12 Pfizer Inc. Immunogenic compositions for use in pneumococcal vaccines
CN115671274B (zh) * 2022-09-29 2024-03-12 普大生物科技(泰州)有限公司 一种载体蛋白与多糖共价键连接成结合物的方法及应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4221906A (en) 1979-03-19 1980-09-09 American Cyanamid Company Stabilization of pneumococcal polysaccharides
US4242501A (en) 1979-08-08 1980-12-30 American Cyanamid Company Purification of pneumococcal capsular polysaccharides
US4686102A (en) 1984-04-12 1987-08-11 American Cyanamid Company Multivalent pneumococcal vaccine and preparation thereof
CA2059692C (en) 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
CA2059693C (en) 1991-01-28 2003-08-19 Peter J. Kniskern Polysaccharide antigens from streptococcus pneumoniae
JP4057576B2 (ja) 2004-10-08 2008-03-05 財団法人浜松科学技術研究振興会 靴底用中敷
US7709001B2 (en) * 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
US8808707B1 (en) 2006-05-08 2014-08-19 Wyeth Llc Pneumococcal dosing regimen
BRPI0715396B8 (pt) * 2006-08-07 2021-05-25 Harvard College método de produção de uma composição para vacina
TW201136603A (en) * 2010-02-09 2011-11-01 Merck Sharp & Amp Dohme Corp 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition
GB201003922D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Conjugation process
KR102057217B1 (ko) * 2012-06-20 2020-01-22 에스케이바이오사이언스 주식회사 다가 폐렴구균 다당류-단백질 접합체 조성물
ITMI20130142A1 (it) * 2013-01-31 2014-08-01 Biosynth Srl Vaccini glicoconiugati comprendenti unita' di base di un costrutto molecolare esprimente epitopi multipli incorporati
US11576958B2 (en) 2013-02-07 2023-02-14 Children's Medical Center Corporation Protein antigens that provide protection against pneumococcal colonization and/or disease
CN104069488A (zh) * 2013-03-29 2014-10-01 北京科兴中维生物技术有限公司 多价肺炎球菌荚膜多糖-蛋白质共轭组合物及其制备方法
WO2015006555A2 (en) 2013-07-10 2015-01-15 Sutro Biopharma, Inc. Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use
AU2014286990A1 (en) 2013-07-11 2016-02-11 Novartis Ag Lysine-specific chemoenzymatic protein modifications using microbial transglutaminase
MY191539A (en) 2015-03-26 2022-06-30 Gpn Vaccines Pty Ltd Streptococcal vaccine
US11147863B2 (en) * 2015-06-23 2021-10-19 Biological E Limited Multivalent pneumococcal conjugate vaccine
KR102225282B1 (ko) 2015-07-21 2021-03-10 화이자 인코포레이티드 접합된 캡슐형 사카라이드 항원을 포함하는 면역원성 조성물, 그를 포함하는 키트 및 그의 용도
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
EP3436061A4 (en) * 2016-03-31 2019-12-04 Liffey Biotech Limited Saccharide-polypeptide-conjugate compositions and methods of use thereof
NZ752348A (en) 2016-09-30 2022-11-25 Biological E Ltd Multivalent pneumococcal vaccine compositions comprising polysaccharide-protein conjugates
WO2019070994A1 (en) * 2017-10-04 2019-04-11 Liffey Biotech Limited SACCHARIDE-POLYPEPTIDE CONJUGATE COMPOSITIONS AND METHODS OF USE

Similar Documents

Publication Publication Date Title
JP2019513821A5 (https=)
US12295998B2 (en) Enhancing immunogenicity of Streptococcus pneumoniae polysaccharide-protein conjugates
JP7690523B2 (ja) 多価肺炎球菌多糖体－タンパク質複合体組成物
KR102225282B1 (ko) 접합된 캡슐형 사카라이드 항원을 포함하는 면역원성 조성물, 그를 포함하는 키트 및 그의 용도
Khatun et al. An overview of structural features of antibacterial glycoconjugate vaccines that influence their immunogenicity
JP2022105155A (ja) 多糖類－タンパク質コンジュゲートを含む多価肺炎球菌ワクチン組成物
ES2546186T3 (es) Procedimiento de fabricación de vacunas
JP2020533438A5 (https=)
BR112020014978A2 (pt) Composição de conjugado polissacarídeo-proteína pneumocócico multivalente
CN103402544A (zh) 缀合方法
MX2012010388A (es) Proceso de conjugacion de polisacaridos bacterianos con proteinas portadoras.
JP2018516962A5 (https=)
KR20130098362A (ko) 면역원성 조성물
JP2018518512A (ja) 多価肺炎球菌コンジュゲートワクチン
Lockhart Conjugate vaccines
BR112015016817B1 (pt) métodos para derivar um sacarídeo, para conjugar um derivado de sacarídeo e para incitar uma resposta imune em um mamífero, derivado de sacarídeo, conjugado de um derivado de sacarídeo, composição farmacêutica, e, uso de um conjugado ou composição farmacêutica
KR20200018784A (ko) 신규 다가 다당류-단백질 접합체 백신 조성물 및 이의 제형
EP3817775B1 (en) Improvements in immunogenic conjugates
AU2020355401B2 (en) Neisseria meningitidis compositions and methods thereof
HK40117919A (zh) 包含缀合荚膜糖抗原的免疫原性组合物及其用途
RU2023120100A (ru) Пневмококковые полисахариды и их применение в иммуногенных конъюгатах полисахарид-белок-носитель
RU2020112314A (ru) Пневмококковые полисахариды и их применение в иммуногенных конъюгатах полисахарид-белок-носитель
HK40023130B (zh) 包含缀合荚膜糖抗原的免疫原性组合物及其用途
Michon Structural Properties of Group B Streptococcal Type III Polysaccharide Conjugate Vaccines That Influence Immunogenicity and Efficacy
HK40050310B (en) Improvements in immunogenic conjugates